Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bright

Showing results (61-70 of 347) with videos related to

Pageof 35
Sort By:
NAM Perspectives|January 20, 2025
AI-Enabled Protein Design: A Strategic Asset for Global Health and BiosecurityLynda M Stuart, Rick A Bright, Eric Horvitz
Traffic (Copenhagen, Denmark)|August 23, 2002
The lumenal domain of the integral membrane protein phogrin mediates targeting to secretory granulesChristina Wasmeier, Nicholas A Bright, John C Hutton
Nutrition (Burbank, Los Angeles County, Calif.)|July 13, 2001
International perspectives: the profession of dieteticsK S Calabro, K A Bright, S Bahl
Anesthesia and Analgesia|April 27, 2001
Can inflammatory pain prevent the development of acute tolerance to alfentanil?I Kissin, C A Bright, E L Bradley
Journal of Cell Science|December 1, 1996
The effects of cytochalasin D and phorbol myristate acetate on the apical endocytosis of ricin in polarised Caco-2 cellsW Shurety, N A Bright, J P Luzio
Anesthesia and Analgesia|June 27, 2000
Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systemsI Kissin, C A Bright, E L Bradley
Anesthesia and Analgesia|April 26, 2002
Selective and long-lasting neural blockade with resiniferatoxin prevents inflammatory pain hypersensitivityIgor Kissin, Cheryl A Bright, Edwin L Bradley
Anesthesia and Analgesia|November 30, 2000
The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations?I Kissin, C A Bright, E L Bradley
Journal of Clinical Epidemiology|January 1, 1989
Medicaid data as a resource for epidemiologic studies: strengths and limitationsR A Bright, J Avorn, D E Everitt
JAMA|May 10, 2022
Testing, Surveillance, and Mitigation Strategies for COVID-19-ReplyEzekiel J Emanuel, David Michaels, Rick A Bright
Pageof 35

Showing results (61-70 of 347) with videos related to

Sort By:
Pageof 35
NAM Perspectives|January 20, 2025
AI-Enabled Protein Design: A Strategic Asset for Global Health and BiosecurityLynda M Stuart, Rick A Bright, Eric Horvitz
Traffic (Copenhagen, Denmark)|August 23, 2002
The lumenal domain of the integral membrane protein phogrin mediates targeting to secretory granulesChristina Wasmeier, Nicholas A Bright, John C Hutton
Nutrition (Burbank, Los Angeles County, Calif.)|July 13, 2001
International perspectives: the profession of dieteticsK S Calabro, K A Bright, S Bahl
Anesthesia and Analgesia|April 27, 2001
Can inflammatory pain prevent the development of acute tolerance to alfentanil?I Kissin, C A Bright, E L Bradley
Journal of Cell Science|December 1, 1996
The effects of cytochalasin D and phorbol myristate acetate on the apical endocytosis of ricin in polarised Caco-2 cellsW Shurety, N A Bright, J P Luzio
Anesthesia and Analgesia|June 27, 2000
Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systemsI Kissin, C A Bright, E L Bradley
Anesthesia and Analgesia|April 26, 2002
Selective and long-lasting neural blockade with resiniferatoxin prevents inflammatory pain hypersensitivityIgor Kissin, Cheryl A Bright, Edwin L Bradley
Anesthesia and Analgesia|November 30, 2000
The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations?I Kissin, C A Bright, E L Bradley
Journal of Clinical Epidemiology|January 1, 1989
Medicaid data as a resource for epidemiologic studies: strengths and limitationsR A Bright, J Avorn, D E Everitt
JAMA|May 10, 2022
Testing, Surveillance, and Mitigation Strategies for COVID-19-ReplyEzekiel J Emanuel, David Michaels, Rick A Bright
Pageof 35